Invention Grant
- Patent Title: Use of an active ingredient combination that contains hydroxystilbene for preventing and/or treating diseases
- Patent Title (中): 使用含有羟基茋的活性成分组合来预防和/或治疗疾病
-
Application No.: US11883685Application Date: 2006-02-03
-
Publication No.: US08268792B2Publication Date: 2012-09-18
- Inventor: Peter Heger , Reinhard Rettenberger , Carl-Friedrich Spaich
- Applicant: Peter Heger , Reinhard Rettenberger , Carl-Friedrich Spaich
- Applicant Address: DE Ubstadt-Weiher DE Heiningen DE Goppingen
- Assignee: Peter Heger,Carl-Friedrich Spaich,Reinhard Rettenberger
- Current Assignee: Peter Heger,Carl-Friedrich Spaich,Reinhard Rettenberger
- Current Assignee Address: DE Ubstadt-Weiher DE Heiningen DE Goppingen
- Agency: Edwards Wildman Palmer LLP
- Agent Peter C. Lauro, Esq.; Weiying Yang, Esq.
- Priority: DE102005005268 20050204; DE102005005270 20050204; DE102005005271 20050204; DE102005005273 20050204; DE102005005274 20050204; DE102005005275 20050204; DE102005005276 20050204; DE102005023164 20050519
- International Application: PCT/EP2006/000951 WO 20060203
- International Announcement: WO2006/082068 WO 20060810
- Main IPC: A61K31/05
- IPC: A61K31/05 ; A61P25/24
Abstract:
The invention relates to the use of a combination of active ingredients, consisting essentially of rhaponticin and deoxyrhaponticin, their functional derivatives or the stereoisomeric forms thereof, in the form of salts or phenol respectively, for producing an agent for the prevention and/or treatment of diseases, whose occurrence and/or progress is associated with an increased IL-6 serum level and/or whose occurrence and/or progress can be treated by a dose of a selective oestrogen receptor β (ER-β) agonist.
Public/Granted literature
Information query
